ApoB-100 R3500Q mutation in the Lebanese population: Prevalence and historical review of the literature

Molecular Biology Reports

Volumn 34, Issue 4, 2007, Pages 267-270

  Sabbagh, Amira S ^a   Daher, Rose T ^a   Otrock, Zaher K ^a   Khalek, Rabab N Abdel ^a   Zaatari, Ghazi S ^a   Mahfouz, Rami A R ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Apo B; Lebanon; Prevalence; R3500Q

Indexed keywords

APOLIPOPROTEIN B100;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE MUTATION; GENOTYPE; HLA SYSTEM; HUMAN; ISRAEL; LEBANON; MALE; MUTATION RATE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; R3500Q GENE; SPAIN; TURKEY (REPUBLIC);

APOLIPOPROTEIN B-100; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LEBANON; MALE; MUTATION, MISSENSE;

EID: 35449001188     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-006-9041-7     Document Type: Article

References (36)

1. Innerarity T, Mahley R, Weisgraber K et al (1990) Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. J Lipid Res 31:1337-1349
2. Tybjærg-Hansen A, Gallagher J, Vincent J, Houlston R, Talmud P, Dunning A et al (1990) Familial defective apolipoprotein B-100: detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases. Atherosclerosis 80:235-242
3. Goldstein JL, Hobbs HH, Brown MS (1995) In: The metabolic and molecular bases of inherited disease, 7th edn. McGraw-Hill, New York, pp 1981-2030
4. Soria LF, Ludwig EH, Clarke HRG, Vega GL, Grundy SM, McCarty BJ (1989) Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci USA 86:587-591
5. Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47
6. Boren J, Ekstrom U, Agren B, Nilsson-Ehle P, Innerarity TL (2001) The molecular mechanism for the genetic disorder familial defective apolipoprotein B100. J Biol Chem 276:9214-9218
7. Blackhart B, Ludwig E, Pierotti V, Ciaiati L, Onasch M, Wallis S et al (1986) Structure of the human apolipoprotein B gene. J Biol Chem 261:15364-15367
8. Innerarity T, Weisgraber K, Arnold K, Mahley R, Krauss R, Vega GL et al (1987) Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc Natl Acad Sci USA 84:6919-6923
9. Horvath A, Ganev V (2001) The mutation APOB-100 R3500Q in Eastern Europe. Atherosclerosis 156:241-242
10. Schuster H, Rauh G, Kormann B, Hepp T, Humphries S, Keller C et al (1990) Familial defective apolipoprotein B-100. Comparison with familial hypercholesterolemia in 18 cases detected in Munich. Arteriosclerosis 10:577-581
11. Le Tensorer J-M, Niffeler U (1993) Verlag Schweizerische Gesellschaft für Ur- und Frühgeschichte, pp 203-241 (Deutsch)
12. Myant N, Forbes S, Day I, Dallagher J (1997) Estimation of the age of the ancestral arginine3500 - >glutamine mutation in human apoB-100. Genomics 45:78-87
13. Miserez AR, Laager R, Chiodetti N, Keller U (1994) High prevalence of familial defective apolipoprotein B-100 in Switzerland. J Lipid Res 35:574-583
14. Kotze MJ, Peeters AV, Langenhoven E, Wauters JG, Van Gaal LF (1994) Phenotypic expression and frequency of familial defective apolipoprotein B-100 in Belgian hypercholesterolemics. Atherosclerosis 111:217-225
15. Bersot TP, Russell SJ, Thatcher SR, Pomernacki NK, Mahley RW, Weisgraber KH et al (1993) A unique haplotype of the apolipoprotein B-100 allele associated with familial defective apolipoprotein B-100 in a Chinese man discovered during a study of the prevalence of this disorder. J Lipid Res 34:1149-1154
16. Hämälainen T, Palotie A, Aalto-Setala K, Kontula K, Tilkanen M (1990) Absence of familial defective apolipoprotein B-100 in Finnish patients with elevated serum cholesterol. Atherosclerosis 82:177-183
17. Seripa D, Gravina C, Volpe R, Margaglione M, Papa S, Merla G et al (1999) Absence of apolipoprotein B3500 mutation in type 2a hyperlipoproteinemia patients and in the general population from southern Italy. J Inherit Metab Dis 22:670-671
18. Real JT, Chaves JF, Ascaso JF, Armengod ME, Carmena R (1999) Familial defect of apo B-100 in subjects with clinically diagnosed primary hypercholesterolemia: identification of the first family with this disorder in Spain. Med Clin (Barc) 113:15-17 (Spanish)
19. Mahley RW, Palaoglu KE, Atak Z et al (1995) Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 36:839-859
20. Horvath A, Savov A, Kirov S et al (2001) High frequency of the ApoB-100 R3500Q mutation in Bulgarian hypercholesterolaemic subjects. J Med Genet 38(8):536-540
21. Zakharova FM, Damgaard D, Mandelshtam MY, Golubkov VI, Nissen PH, Nilsen GG et al (2005) Familial hypercholesterolemia in St-Petersburg: the known and novel mutations found in the low density lipoprotein receptor gene in Russia. BMC Med Genet 8:6
22. Shevtsov SP (1996) Absence of DNA polymorphisms on the region of the APOV gene coding the proposed low density lipoprotein-binding domain of the ApoB-100 protein. Genetika 32:295-297 (Russian)
23. Krapivner SR, Malyshev PP, Rozhkova TA, Poltaraus AB, Kukharchuk VV, Bochkov VN (2000) Application of DNA analysis for differential diagnosis of familial hypercholesterolemia and familial defect of apolipoprotein b-100. Ter Arkh 72:9-12 (Article in Russian)
24. Dedoussis GV, Genschel J, Bochow B, Pitsavos C, Skoumas J, Prassa M et al (2004) Molecular characterization of familial hypercholesterolemia in German and Greek patients. Hum Mutat 23(3):285-286
25. Kalina A, Czeizel E, Romics L, Pados G, Reiber I, Dosa A et al (1998) Incidence of familial defective apolipoprotein B-100 in cases of patients diagnosed with familial hypercholesterolemia. Orv Hetil 139:755-759 (Article in Hangarian)
26. Thiart R, Varret M, Lintott CJ, Scott RS, Loubser O, du Plessis L et al (2000) Mutation analysis in a small cohort of New Zealand patients originating from the United Kingdom demonstrates genetic heterogeneity in familial hypercholesterolemia. Mol Cell Probes 14(5):299-304
27. Teng YN, Pan JP, Chou SC, Tai DY, Lee-Chen GJ (2000) Familial defective apolipoprotein B-100: detection and haplotype analysis of the Arg(3500)- >Gln mutation in hyperlipidemic Chinese. Atherosclerosis 152(2):385-390
28. Friedlander Y, Dann EJ, Leitersdorf E (1993) Absence of familial defective apolipoprotein B-100 in Israeli patients with dominantly inherited hypercholesterolemia and in offspring with parental history of myocardial infarction. Hum Genet 91:299-300
29. Sozen MM, Whittall R, Oner C, Tokatli A, Kalkanoglu HS, Dursun A, Coskun T, Oner R, Humphries SE (2005) The molecular basis of familial hypercholesterolaemia in Turkish patients. Atherosclerosis 180(1):63-71
30. El Messal M, Ait Chihab K, Chater R, Vallve JC, Bennis F, Hafidi A et al (2003) Familial hypercholesterolemia in Morocco: first report of mutations in the LDL receptor gene. J Hum Genet 48(4):199-203
31. Castillo S, Tejedor D, Mozas P, Reyes G, Civeira F, Alonso R et al (2002) The apolipoprotein B R3500Q gene mutation in Spanish subjects with a clinical diagnosis of familial hypercholesterolemia. Atherosclerosis 165(1):127-135
32. Gorski B, Kubalska J, Naruszewicz M, Lubinski J (1998) LDL-R and Apo-B-100 gene mutations in Polish familial hypercholesterolemias. Hum Genet 102:562-565
33. Ceska R, Vrablik M, Horinek A (2000) Familial defective apolipoprotein B-100: a lesson from homozygous and heterozygous patients. Physiol Res 49(Suppl 1):S12
34. Kalina A, Császár A, Czeizel A et al (1998) Incidence of familial defective apolipoprotein B-100 in cases of patients diagnosed with familial hypercholesterolemia. Atherosclerosis 154:247-251
35. Rosser ZH, Zerjal T, Hurles ME, Adojaan M, Alavantic D, Amorim A et al (2000) Y-chromosomal diversity in Europe is clinal and influenced primarily by geography, rather than by language. Am J Hum Genet 67(6):1526-1543
36. Miserez AR, Muller PY (2000) Familial defective apolipoprotein B-100: a mutation emerged in the mesolithic ancestors of Celtic peoples? Atherosclerosis 148:433-436